| Intrinsic Valuation of: SMMT | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -1 | Market Cap | $18B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $436M | |||||
| 2022 | $-73M | - (-) | Net Income | $-221M | Total Debt | $0 | |||||
| 2023 | $-42M | 42.1% (-48.6%) | EBITDA | $-213M | Total Liab | $47M | |||||
| 2024 | $-77M | -82.2% (-%) | Opr Margin | - | Debt/Equity | - | |||||
| 2025 | $-142M | -85.0% (-%) | PreTax Margin | - | BV/Share | 1 | |||||
| 5Y Average FCF | $-84M | -41.7% (-%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | $-87M | MBG Intrinsic Value | $-9 | ||||||||
| 2027 | $-90M | ||||||||||
| 2028 | $-94M | ||||||||||
| 2029 | $-98M | ||||||||||
| 2030 | $-102M | ||||||||||
| 2031 | $-106M | ||||||||||
| Terminal Value | $-2B | Net Worth/Share | $1 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $-2B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $105M | $-2 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 7.3% | -2 | -2 | -2 | -3 | -3 | |||
| Equity Value | $-2B | 7.4% | -2 | -2 | -2 | -3 | -3 | ||||
| Shares Outstanding | 742,846,976 | 7.4% | -2 | -2 | -2 | -3 | -3 | ||||
| 7.9% | -2 | -2 | -2 | -2 | -3 | ||||||
| DCF Intrinsic Value | $-2 | 8.4% | -2 | -2 | -2 | -2 | -2 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||